Analyst Ratings For Spire Healthcare Group PLC (LON:SPI)
Today, J P Morgan Chase & Co reiterated its Neutral rating on Spire Healthcare Group PLC (LON:SPI) with a price target of GBX 433.
There are 1 sell rating, 5 hold ratings, 4 buy ratings on the stock.
The current consensus rating on Spire Healthcare Group PLC (LON:SPI) is Hold (Score: 2.30) with a consensus target price of GBX 361.50 per share, a potential .
Some recent analyst ratings include
- 3/3/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 3/2/2017-Numis Securities Ltd Reiterated Rating of Add.
- 3/2/2017-Liberum Capital Reiterated Rating of Buy.
- 2/9/2017-Berenberg Bank Reiterated Rating of Buy.
- 1/12/2017-Morgan Stanley Reiterated Rating of Equal weight.
About Spire Healthcare Group PLC (LON:SPI)
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company’s serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company’s primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.
Recent Trading Activity for Spire Healthcare Group PLC (LON:SPI)
Shares of Spire Healthcare Group PLC closed the previous trading session at 330.30 down -1.80 -0.54% with 1,403,504 shares trading hands.